Strategic collaboration reflects both
companies’ focus on providing customers access to affordable
in-store health care services
Walgreens and LabCorp® (NYSE: LH) today announced their mutual
commitment to a significant expansion of their LabCorp at Walgreens
collaboration. The two companies have agreed to open at least 600
LabCorp patient service centers at Walgreens stores across the U.S.
over the next four years, inclusive of the 17 locations that have
opened since they first announced their consumer-focused initiative
in June 2017.
LabCorp at Walgreens locations are currently open in Florida,
Colorado, North Carolina and Deerfield, Illinois, serving as an
important part of LabCorp’s network of nearly 2,000 patient service
centers across the U.S. Consumers and healthcare providers continue
to have a positive response to the existing locations, which offer
specimen collection services for LabCorp testing in a secure,
comfortable environment. The sites are located near the pharmacy
area inside the Walgreens store, providing a convenient location
for consumers to access important health services and
information.
“LabCorp’s strong partnership on this joint initiative, coupled
with the enthusiastic consumer feedback we’ve received, allows us
to undertake an exciting expansion of our collaboration together,”
said Stefano Pessina, executive vice chairman and CEO of Walgreens
Boots Alliance, Inc. “This reflects our commitment to transform our
stores into neighborhood health destinations that provide a
differentiated, consumer-focused experience, while providing access
to a broad range of affordable health care services at a trusted
and convenient setting.”
“We chose a partner with shared values and a shared vision of
creating a differentiated consumer-focused experience, which has
led to an extremely successful collaboration,” said David P. King,
LabCorp’s chairman and CEO. “LabCorp at Walgreens is a central
piece of our expanding consumer strategy, as we continue to create
new channels for our offering by meeting consumers where they want
to be met, extending the reach of our mission to improve health and
improve lives.”
In addition, the companies are pursuing other collaboration
opportunities, to take advantage of LabCorp’s unique combination of
diagnostics and drug development expertise, and Walgreens leading
experience in pharmacy, retail health and consumer engagement. The
parties are exploring novel approaches to clinical research,
helping consumers take a greater role in their own health and
well-being, enabling the ongoing transition to value-based care,
and expanding the health-related services available at LabCorp at
Walgreens.
LabCorp at Walgreens locations offer collection of specimens for
a broad range of laboratory testing that is performed in LabCorp’s
nationwide network of regional and specialty laboratories.
Appointments for all LabCorp at Walgreens locations may be made in
advance at LabCorp.com/Walgreens, as well as through the
LabCorp|Patient online portal and app, which is available for both
Android and iOS. All locations feature the proprietary
LabCorp|Express tablet-based system for expedited check-in.
Information about LabCorp at Walgreens, including locations, is
available on Walgreens Find Care Now digital platform and
marketplace that helps connect the company’s millions of mobile and
online visitors to health care services at Walgreens stores.
About LabCorp
LabCorp (NYSE: LH), an S&P 500 company, is a leading global
life sciences company that is deeply integrated in guiding patient
care, providing comprehensive clinical laboratory and end-to-end
drug development services. With a mission to improve health and
improve lives, LabCorp delivers world-class diagnostic solutions,
brings innovative medicines to patients faster and uses technology
to improve the delivery of care. LabCorp reported net revenues of
over $10 billion in 2017. To learn more about LabCorp,
visit www.labcorp.com, and to
learn more about Covance Drug Development, visit www.covance.com.
About Walgreens
Walgreens (walgreens.com), one of the nation's largest drugstore
chains, is included in the Retail Pharmacy USA Division of
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the first global
pharmacy-led, health and wellbeing enterprise. Approximately 8
million customers interact with Walgreens in stores and online each
day, using the most convenient, multichannel access to consumer
goods and services and trusted, cost-effective pharmacy, health and
wellness services and advice. As of June 28, 2018, Walgreens
operates approximately 9,800 drugstores with a presence in all 50
states, the District of Columbia, Puerto Rico and the U.S. Virgin
Islands, along with its omnichannel business, Walgreens.com.
Approximately 400 Walgreens stores offer Healthcare Clinic or other
provider retail clinic services.
(WBA-GEN)
Forward-Looking Statements
All statements in this release that are not historical are
forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are not guarantees of future
performance and involve risks, assumptions and uncertainties,
including, but not limited to, those related to the timing and
effectiveness of collaboration plans, the ability to realize the
anticipated benefits of the collaboration, competitive actions in
the marketplace, and the ability to achieve anticipated financial
and operating results in the amounts and at the times anticipated,
as well as those described in Item 1A (Risk Factors) of Walgreens
Boots Alliance, Inc.’s Form 10-K for its fiscal year ending August
31, 2017, LabCorp’s Form 10-K for its fiscal year ending December
31, 2017, and subsequent documents that Walgreens Boots Alliance,
Inc. and LabCorp file or furnish with the Securities and Exchange
Commission. Should one or more of these risks or uncertainties
materialize, or should underlying assumptions prove incorrect,
actual results may vary materially. These forward-looking
statements speak only as of the date they are made. Except to the
extent required by law, each of Walgreens Boots Alliance, Inc.,
Walgreens and LabCorp do not undertake, and expressly disclaim, any
duty or obligation to update publicly any forward-looking statement
after the date of this release, whether as a result of new
information, future events, changes in assumptions or
otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181010005979/en/
LabCorp:Donald Von Hagen; 336-436-8263;
Media@labcorp.comorWalgreens:Scott Goldberg; 847-315-7649;
scott.goldberg@walgreens.com
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Apr 2023 to Apr 2024